← Back to Search

Behavioral Intervention

Team-Based Care for HIV (ARTAS Trial)

N/A
Recruiting
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 90 days post-study enrollment hospitalization discharge
Awards & highlights

ARTAS Trial Summary

This trial studied how team-based care affects HIV patients' ability to link to follow-up care and hospital readmission rates.

Who is the study for?
This trial is for adults over 18 who are newly diagnosed with HIV, or those known to have HIV but haven't started antiretroviral therapy (ART) within the last month. It's also open to patients not virally suppressed or those without specialist care in the past 6 months. People actively on ART, virally suppressed, and under recent specialist care can't join.Check my eligibility
What is being tested?
The study compares a team-based approach called ARTAS for managing HIV in a hospital setting against the usual standard of care. The goal is to see if this method improves patient follow-up treatment and reduces readmissions.See study design
What are the potential side effects?
Since this trial focuses on intervention methods rather than medications, side effects aren't typical as with drug trials. However, there may be indirect effects related to changes in care management that will be monitored.

ARTAS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 90 days post-study enrollment hospitalization discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 90 days post-study enrollment hospitalization discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of linkage to HIV care post discharge
Secondary outcome measures
Readmission Rate after initial post-study hospitalization

ARTAS Trial Design

2Treatment groups
Active Control
Group I: Standard of Care Historic ControlActive Control1 Intervention
Control group will get treatment as usual, which consists of medical care by primary admitting service
Group II: Team based inpatient ARTASActive Control1 Intervention
Eligible patients after the study consent process will receive Antiretroviral Treatment Access Study (ARTAS) intervention by social-worker and a medical consultation by an infectious disease physician

Find a Location

Who is running the clinical trial?

Gilead SciencesIndustry Sponsor
1,084 Previous Clinical Trials
848,012 Total Patients Enrolled
Loma Linda UniversityLead Sponsor
306 Previous Clinical Trials
260,734 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is the experiment's participant pool being extended?

"Affirmative. Clinicaltrials.gov has evidence that this clinical trial is presently recruiting, having first been posted on October 16th 2023 and last updated on the 27th of same month. 250 patients are needed across a single research site."

Answered by AI

Is enrollment for this clinical investigation still open?

"Affirmative. The clinicaltrials.gov website attests to the fact that this medical trial is still actively recruiting participants, despite having been first published on October 16th 2023 and last modified on October 27th 2023. 250 patients are needed for this study at a single site of recruitment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Teamwork Makes the Dream Work
Jennifer Veltman 2023. "Teamwork Makes the Dream Work". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05866523.
~167 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top